A system for managing female incontinence includes a body of biocompatible material configured to fit between the labia minora and the vestibule floor, the body having a surface configured to occlude the urethral meatus, a first adhesive layer disposed on at least a first portion of the surface and configured to provide a sealing engagement between the body and the urethral meatus, and a second adhesive layer disposed over the first adhesive layer and configured to provide a sealing engagement between the body and the urethral meatus, wherein the second adhesive layer is removable from the first adhesive layer.

Medical devices with a hydrogel layer covalently attached to a portion of the outer surface of the medical device are provided along with methods for applying the coating. The hydrogel layer can include a first polymer species comprising polyethylene glycol (PEG) and a second polymer species. Examples of the second polymer species include PEG and polyacrylamide (PAM). The first and second species can be at least partially cross-linked. Methods for forming the hydrogel coatings on the medical devices are provided including nucleophilic conjugate reactions, such as Click reactions.

Medical devices with a hydrogel layer covalently attached to a portion of the outer surface of the medical device are provided along with methods for applying the coating. The hydrogel layer can include a first polymer species comprising polyethylene glycol (PEG) and a second polymer species. Examples of the second polymer species include PEG and polyacrylamide (PAM). The first and second species can be at least partially cross-linked. Methods for forming the hydrogel coatings on the medical devices are provided including nucleophilic conjugate reactions, such as Click reactions.

The present invention relates to a process for producing water-absorbing polymer particles having an improved profile of properties, comprising thermal surface postcrosslinking in the presence of a salt of a polyvalent metal cation and a complexing anion and subsequent aftertreatment, the aftertreatment comprising coating with a salt of a polyvalent metal cation and a non-complexing anion, and remoisturization with further drying.

The present invention relates to a process for producing water-absorbing polymer particles having an improved profile of properties, comprising thermal surface postcrosslinking in the presence of a salt of a polyvalent metal cation and a complexing anion and subsequent aftertreatment, the aftertreatment comprising coating with a salt of a polyvalent metal cation and a non-complexing anion, and remoisturization with further drying.

An absorbent wound dressing comprises a hydrophilic porous substrate and polymer-stabilized silver nanoparticles distributed throughout the porous substrate. The silver nanoparticles have a particle size d.sub.50 in the range of about 45 nm to about 85 nm and the silver nanoparticles are present in the substrate in an amount of about 0.16% to about 1.5% by weight of the total weight of the substrate. The wound dressing produces a 7-day log reduction of 4 or more for bacteria in accordance with the Modified AATCC Test Method 100. The wound dressing is also non-cytotoxic in accordance with ISO 10993-5 standard procedure for medical device cytotoxicity assessment.

An absorbent wound dressing comprises a hydrophilic porous substrate and polymer-stabilized silver nanoparticles distributed throughout the porous substrate. The silver nanoparticles have a particle size d.sub.50 in the range of about 45 nm to about 85 nm and the silver nanoparticles are present in the substrate in an amount of about 0.16% to about 1.5% by weight of the total weight of the substrate. The wound dressing produces a 7-day log reduction of 4 or more for bacteria in accordance with the Modified AATCC Test Method 100. The wound dressing is also non-cytotoxic in accordance with ISO 10993-5 standard procedure for medical device cytotoxicity assessment.

The present application relates to a medical hydrogel comprising nanofibrillar cellulose, wherein the content of nanofibrillar cellulose in the hydrogel is in the range of 1-3.5% (w/w), and the nanofibrillar cellulose comprises anionic nanofibrillar cellulose having an average fibril diameter of 200 nm or less, and to a method for preparing thereof. The present application also relates to the medical hydrogel for use for inducing vascularization in wounds and/or for treating deep wounds of dermis and/or below tissue.

This invention relates to novel non-composite and composite superabsorbents, wherein the dry superabsorbents are xerogels, more particularly the bio-xerogels or the composites, particularly the biocomposites, more particularly the bionanocomposites and the method(s) of obtaining the same characterized by simultaneous in situ grafting and cross linking of ethylinically unsaturated monomers on to a single biopolymer of plant or animal origin, or on combination of different biopolymers or biopolymer(s) or/and clay(s), in a homogeneous polar phase, in the presence of initiator and crosslinker of chemical or non-chemical origin, at a temperature of 40 to 90° C., achieved by conventional or microwave heating, reaction time varying from instantaneous to 48 hours, involving use of alkali, either in situ or post reaction at room or elevated temperatures for achieving superior absorbency, in an inert or ambient reaction environment, to yield a neutral or near neutral product.

This invention relates to novel non-composite and composite superabsorbents, wherein the dry superabsorbents are xerogels, more particularly the bio-xerogels or the composites, particularly the biocomposites, more particularly the bionanocomposites and the method(s) of obtaining the same characterized by simultaneous in situ grafting and cross linking of ethylinically unsaturated monomers on to a single biopolymer of plant or animal origin, or on combination of different biopolymers or biopolymer(s) or/and clay(s), in a homogeneous polar phase, in the presence of initiator and crosslinker of chemical or non-chemical origin, at a temperature of 40 to 90° C., achieved by conventional or microwave heating, reaction time varying from instantaneous to 48 hours, involving use of alkali, either in situ or post reaction at room or elevated temperatures for achieving superior absorbency, in an inert or ambient reaction environment, to yield a neutral or near neutral product.